Technical Analysis for AZTR - Azitra Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
50 DMA Resistance | Bearish | -0.73% | |
Inside Day | Range Contraction | -0.73% | |
Wide Bands | Range Expansion | -0.73% | |
20 DMA Support | Bullish | -2.85% | |
Wide Bands | Range Expansion | -2.85% | |
Crossed Above 20 DMA | Bullish | -5.66% | |
Doji - Bearish? | Reversal | -5.66% |
Alert | Time |
---|---|
50 DMA Resistance | about 19 hours ago |
Down 3% | about 19 hours ago |
Up 3% | about 19 hours ago |
Down 2 % | about 19 hours ago |
Up 2% | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.18 |
52 Week Low | 0.1605 |
Average Volume | 663,732 |
200-Day Moving Average | 1.42 |
50-Day Moving Average | 0.23 |
20-Day Moving Average | 0.21 |
10-Day Moving Average | 0.21 |
Average True Range | 0.03 |
RSI (14) | 45.05 |
ADX | 24.73 |
+DI | 19.33 |
-DI | 24.39 |
Chandelier Exit (Long, 3 ATRs) | 0.17 |
Chandelier Exit (Short, 3 ATRs) | 0.25 |
Upper Bollinger Bands | 0.25 |
Lower Bollinger Band | 0.17 |
Percent B (%b) | 0.64 |
BandWidth | 37.04 |
MACD Line | -0.02 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0124 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.25 | ||||
Resistance 3 (R3) | 0.25 | 0.24 | 0.24 | ||
Resistance 2 (R2) | 0.24 | 0.23 | 0.24 | 0.24 | |
Resistance 1 (R1) | 0.23 | 0.23 | 0.23 | 0.23 | 0.24 |
Pivot Point | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
Support 1 (S1) | 0.21 | 0.21 | 0.21 | 0.21 | 0.20 |
Support 2 (S2) | 0.20 | 0.21 | 0.20 | 0.20 | |
Support 3 (S3) | 0.19 | 0.20 | 0.20 | ||
Support 4 (S4) | 0.19 |